Literature DB >> 7031973

Effect of aerosol and oral fenoterol on histamine and methacholine challenge in asthmatic subjects.

C M Salome, R E Schoeffel, A J Woolcock.   

Abstract

In order to determine the effect of drugs on bronchial hyperreactivity in subjects with asthma, 12 atopic asthmatic volunteers underwent bronchial challenge with either histamine or methacholine on three separate days. Before the challenges no medication was given on the first day, on the second 400 microgram of aerosol fenoterol and on the third 5 mg of oral fenoterol were administered. The aerosol fenoterol caused the dose response curves to both histamine and methacholine to be shifted to the right in all subjects. The oral dose produced no significant change from the control values. The slope of the dose response curves was not altered by either the oral or the aerosol drug. It is concluded that aerosol but not oral fenoterol in the clinical dosage, causes a change in the sensitivity but not in the reactivity of the airway of patients with atopic asthma.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7031973      PMCID: PMC471632          DOI: 10.1136/thx.36.8.580

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  8 in total

1.  Standardization of bronchial inhalation challenge procedures.

Authors:  H Chai; R S Farr; L A Froehlich; D A Mathison; J A McLean; R R Rosenthal; A L Sheffer; S L Spector; R G Townley
Journal:  J Allergy Clin Immunol       Date:  1975-10       Impact factor: 10.793

2.  Protective effect of drugs on histamine-induced asthma.

Authors:  D W Cockcroft; D N Killian; J J Mellon; F E Hargreave
Journal:  Thorax       Date:  1977-08       Impact factor: 9.139

3.  Inhaled and oral bronchodilator therapy in exercise induced asthma.

Authors:  S D Anderson; P J Rozea; R Dolton; D A Lindsay
Journal:  Aust N Z J Med       Date:  1975-12

4.  Airway response to carbachol in normal and asthmatic subjects: distinction between bronchial sensitivity and reactivity.

Authors:  J Orehek; P Gayrard; A P Smith; C Grimaud; J Charpin
Journal:  Am Rev Respir Dis       Date:  1977-06

5.  Evaluation of oral fenoterol in chronic asthmatic patients.

Authors:  P P VanArsdel; R M Schaffrin; J Rosenblatt; A C Sprenkle; L C Altman
Journal:  Chest       Date:  1978-06       Impact factor: 9.410

6.  Spirometric standards for healthy nonsmoking adults.

Authors:  J F Morris; A Koski; L C Johnson
Journal:  Am Rev Respir Dis       Date:  1971-01

7.  Reproducibility and comparison of responses to inhaled histamine and methacholine.

Authors:  E F Juniper; P A Frith; C Dunnett; D W Cockcroft; F E Hargreave
Journal:  Thorax       Date:  1978-12       Impact factor: 9.139

8.  Inhaled and oral salbutamol in exercise-induced asthma.

Authors:  S D Anderson; J P Seale; P Rozea; L Bandler; G Theobald; D A Lindsay
Journal:  Am Rev Respir Dis       Date:  1976-09
  8 in total
  11 in total

1.  Effect of nebulised aerosol size on lung deposition in patients with mild asthma.

Authors:  M M Clay; S W Clarke
Journal:  Thorax       Date:  1987-03       Impact factor: 9.139

Review 2.  The current debate concerning beta-agonists in asthma: a review.

Authors:  K F Chung
Journal:  J R Soc Med       Date:  1993-02       Impact factor: 5.344

3.  Effect of terbutaline sulphate in chronic "allergic" cough.

Authors:  R Ellul-Micallef
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-01

4.  Protective effect of oral oxyphenonium bromide, terbutaline and theophylline against the bronchial obstructive effects of inhaled histamine, acetylcholine and propranolol.

Authors:  G H Koëter; H Meurs; J H Jonkman; J Greving; J Leferink; H J Sluiter; R A de Zeeuw; K de Vries
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

Review 5.  Measurement of bronchial reactivity: a question of interpretation.

Authors:  A E Tattersfield
Journal:  Thorax       Date:  1981-08       Impact factor: 9.139

6.  Effect of different bronchodilators on airway smooth muscle responsiveness to contractile agents.

Authors:  B Gustafsson; C G Persson
Journal:  Thorax       Date:  1991-05       Impact factor: 9.139

7.  Effect of inhaled budesonide on bronchial reactivity to histamine, exercise, and eucapnic dry air hyperventilation in patients with asthma.

Authors:  A S Vathenen; A J Knox; A Wisniewski; A E Tattersfield
Journal:  Thorax       Date:  1991-11       Impact factor: 9.139

8.  The protective effect of a beta 2 agonist against excessive airway narrowing in response to bronchoconstrictor stimuli in asthma and chronic obstructive lung disease.

Authors:  E H Bel; A H Zwinderman; M C Timmers; J H Dijkman; P J Sterk
Journal:  Thorax       Date:  1991-01       Impact factor: 9.139

9.  Dose related effects of salbutamol and ipratropium bromide on airway calibre and reactivity in subjects with asthma.

Authors:  J Britton; S P Hanley; H V Garrett; J W Hadfield; A E Tattersfield
Journal:  Thorax       Date:  1988-04       Impact factor: 9.139

10.  Is nocturnal asthma caused by changes in airway cholinergic activity?

Authors:  J R Catterall; G B Rhind; K F Whyte; C M Shapiro; N J Douglas
Journal:  Thorax       Date:  1988-09       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.